Please assess the completion status of the following clinical trial:

Trial Title: Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Conventional renal cell cancer with a pathological diagnosis~* Metastatic disease~* Consent form signed~* social security regimen affiliated~Exclusion Criteria:~* Other cancer treated

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CA9 level (Type: None): Serum and urinary CA9 level

Based on this trial design, predict the completion outcome and termination type (if applicable).